# MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

> **NCT06095271** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 920 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DIAGNOSTIC_TEST:** serum Neurofilament Filament Light chain (sNfL) monitoring

## Key facts

- **NCT ID:** NCT06095271
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-05
- **Primary completion:** 2026-11
- **Final completion:** 2027-05
- **Target enrollment:** 920 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095271, "MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06095271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*